These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2665993)

  • 1. Serum osteocalcin and bone mineral metabolism following successful renal transplantation.
    Boiskin I; Epstein S; Ismail F; Thomas SB; Raja R
    Clin Nephrol; 1989 Jun; 31(6):316-22. PubMed ID: 2665993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
    Giannini S; D'Angelo A; Carraro G; Antonello A; Di Landro D; Marchini F; Plebani M; Zaninotto M; Rigotti P; Sartori L; Crepaldi G
    Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of bone Gla-protein in normal humans and in patients with chronic renal failure.
    Sugimoto K; Dohi Y; Dohi K; Yonemasu K; Fujimoto J; Kanauchi M; Yamanaka F; Moriyama T; Ishikawa H
    Miner Electrolyte Metab; 1987; 13(3):152-7. PubMed ID: 3498115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acute increases in bone matrix degradation on circulating levels of bone-Gla protein.
    Riggs BL; Tsai KS; Mann KG
    J Bone Miner Res; 1986 Dec; 1(6):539-42. PubMed ID: 3509744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of sex and age on biochemical bone metabolism parameters.
    Resch H; Pietschmann P; Kudlacek S; Woloszczuk W; Krexner E; Bernecker P; Willvonseder R
    Miner Electrolyte Metab; 1994; 20(3):117-21. PubMed ID: 7815999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum osteocalcin (BGP) in tumor-associated hypercalcemia.
    Body JJ; Cleeren A; Pot M; Borkowski A
    J Bone Miner Res; 1986 Dec; 1(6):523-7. PubMed ID: 3509743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.
    Nakashima A; Yorioka N; Doi S; Masaki T; Ito T; Harada S
    Bone; 2004 Mar; 34(3):579-83. PubMed ID: 15003806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
    Singh AK; Avula S; Kher V; Rao DS; Mithal A
    Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
    Charles P; Poser JW; Mosekilde L; Jensen FT
    J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism].
    Motz W
    Acta Med Austriaca; 1989; 16(1):8-12. PubMed ID: 2785325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation.
    Epstein S; Traberg H; Raja R; Poser J
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1253-6. PubMed ID: 3889031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
    Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B
    Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous EDTA treatment on serum parathyroid hormone (1-84) and biochemical markers of bone turnover.
    Guldager B; Brixen KT; Jørgensen SJ; Nielsen HK; Mosekilde L; Jelnes R
    Dan Med Bull; 1993 Nov; 40(5):627-30. PubMed ID: 8299406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood serum osteocalcin and beta-crosslaps concentrations in patients after renal transplantation].
    Zbróg Z; Tomaszek M; Szuflet A; Pierzchalska-Mudyna T; Rybińska A; Skrzypek A; Matych J
    Przegl Lek; 2007; 64(6):431-4. PubMed ID: 18159853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of age on some blood variables relating to bone metabolism in women.
    Willig R; Jalovaara P
    Int J Surg Investig; 2000; 1(6):495-502. PubMed ID: 11729857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H; Papapetrou PD
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.